Last kr121.90 DKK
Change Today +2.80 / 2.35%
Volume 117.9K
LUN On Other Exchanges
Symbol
Exchange
OTC US
Copenhagen
Stuttgart
OTC US
As of 11:02 AM 10/23/14 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

Ottiliavej 9

Valby, 2500

Denmark

Phone: 45 36 30 13 11

Fax: 45 36 30 19 40

H. Lundbeck A/S, a pharmaceutical company, engages in the research and development, production, marketing, and sale of pharmaceuticals for the treatment of CNS disorders, including depression, schizophrenia, Alzheimer’s disease, Parkinson’s disease and insomnia. The company’s products include Circadin for the treatment of primary insomnia; Cipralex, Lexapro, Sipralexa, Sipralex, Cipramil, Seropram, Cipram, and Celexa for the treatment of depression, generalized anxiety disorder, panic disorder, and social anxiety disorder; Ebixa and Ebix for the treatment of moderate to severe Alzheimer’s disease; Azilect for the treatment of Parkinson’s disease; Serdolect and Serlect for the treatment of schizophrenia; and Deanxit for the treatment of mild depression. The company also offers Noritren, Nortrilen, Sensaval, Saroten, Sarotex, and Redomex for depression; and Cisordinol and Clopixol to treat schizophrenia and other psychotic disorders, anxiety, restlessness, and insomnia. The company provides Cisordinol Depot, Clopixol Depot, Ciatyl-Z Depot, Fluanxol Depot, and Depixol to maintain and treat chronic psychotic disorders; and Cisordinol-Acutard, Clopixol-Acutard, Clopixol-Acuphase, and Ciatyl-Z-Acuphase for treating acute psychotic episodes and exacerbation of psychotic disorders. Its other products include Fluanxol, Fluanxol Mite, and Depixol for schizophrenia, other psychotic disorders, and mild depression; and Truxal and Truxaletten for the treatment of schizophrenia and other psychotic disorders, anxiety, restlessness, and withdrawal symptoms in drug addicts. The company has a range of products under clinical development for the treatment of mood disorders, psychoses, neurodegenerative disorders, epilepsy, sleep disorders, and stroke. Partnerships The company has partnership with BioTie Therapies Corp.; Forest Laboratories, Inc.; Merz Pharmaceuticals GmbH; Mochida Pharmaceutical Co.; neurim Pharmaceuticals Ltd.; PAIOn AG; Solvay Pharmaceuticals B.V.; Takeda Pharmaceutical Company Ltd.; Teva Pharmaceutical Industries Ltd.; and Xian-Janssen Pharmaceutical Ltd. History H. Lundbeck A/S was founded in 1915.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LUN:DC kr121.90 DKK +2.80

LUN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alkermes PLC $45.67 USD +1.01
Emergent Biosolutions Inc $21.80 USD +0.49
Impax Laboratories Inc $27.81 USD +0.72
Lupin Ltd 1,391 INR +1.95
Salix Pharmaceuticals Ltd $138.09 USD +0.48
View Industry Companies
 

Industry Analysis

LUN

Industry Average

Valuation LUN Industry Range
Price/Earnings 28.3x
Price/Sales 1.5x
Price/Book 1.6x
Price/Cash Flow 28.3x
TEV/Sales 1.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact H LUNDBECK A/S, please visit www.lundbeck.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.